This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CONNECTIVE_SOFT_NAS_EXALLC for full statistics.
Malignant neoplasm of other connective and soft tissue
C3_CONNECTIVE_SOFT_NAS
lip cancer: Tumors or cancer of the LIP.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C49
Cause of death: ICD-9
171
Cause of death: ICD-8
171
Cancer registry: Topography ICD-O-3
C49
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
549
Check minimum number of events None
549
Include endpoints None
549
Remove individuals based on genotype QC
531
C3_CONNECTIVE_SOFT_NAS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other connective and soft tissue
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of other connective and soft tissue (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 531 | 237 | 294 |
| Unadjusted prevalence (%) | 0.14 | 0.11 | 0.18 |
| Mean age at first event (years) | 58.60 | 57.11 | 59.79 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_CONNECTIVE_SOFT_NAS – Malignant neoplasm of other connective and soft tissue
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of other connective and soft tissue
↥Endpoint not on priority list, no data to show.